Anna Maria Langkilde

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Brian Claggett et al. · New England Journal of Medicine · 2022 · 2.4K citations · Full text

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

Eri Kato, Michael G. Silverman, Ofri Mosenzon et al. · Circulation · 2019 · 550 citations

Food-Related Gastrointestinal Symptoms in the Irritable Bowel Syndrome

Magnus Simrén, Agneta Månsson, Anna Maria Langkilde et al. · Digestion · 2001 · 522 citations

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

Mark C. Petrie, Subodh Verma, Kieran F. Docherty et al. · JAMA · 2020 · 516 citations · Full text

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

David C. Wheeler, Bergur V. Stefánsson, Niels Jongs et al. · The Lancet Diabetes & Endocrinology · 2020 · 498 citations · Full text

Metabolic Syndrome, Hypertension, Renal Function +12